SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-185378
Filing Date
2023-07-11
Accepted
2023-07-11 16:56:03
Documents
14
Period of Report
2023-07-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d519221d8k.htm   iXBRL 8-K 41157
2 EX-99.1 d519221dex991.htm EX-99.1 16349
  Complete submission text file 0001193125-23-185378.txt   248772

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA blacw-20230711.xsd EX-101.SCH 5031
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE blacw-20230711_def.xml EX-101.DEF 15282
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE blacw-20230711_lab.xml EX-101.LAB 26222
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blacw-20230711_pre.xml EX-101.PRE 16446
8 EXTRACTED XBRL INSTANCE DOCUMENT d519221d8k_htm.xml XML 8609
Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004
Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 425-635-7700
Bellevue Life Sciences Acquisition Corp. (Filer) CIK: 0001840425 (see all company filings)

IRS No.: 845052822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41390 | Film No.: 231082635
SIC: 6770 Blank Checks